abrdn Life Sciences Investors logo

abrdn Life Sciences Investors - CE with IsEquityFund

1
NYSE:HQL (USA)   CE with IsEquityFundamentalDataAvailable = 1 in Gid
$ 13.63 -0.02 (-0.15%) 04:00 PM EST
17.25
P/B:
0.91
Market Cap:
$ 365.16M
Enterprise V:
$ 365.16M
Volume:
63.34K
Avg Vol (2M):
109.33K
Volume:
63.34K
Avg Vol (2M):
109.33K

Business Description

abrdn Life Sciences Investors logo
abrdn Life Sciences Investors
NAICS : 523930 SIC : 6282
ISIN : US87911K1007

Share Class Description:

HQL: CE with IsEquityFundamentalDataAvailable = 1 in Gid
Description
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have significant potential for above-average growth.
Name Current Vs Industry Vs History
Cash-To-Debt N/A
N/A
N/A
Equity-to-Asset 1
Debt-to-EBITDA N/A
N/A
N/A
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -45.7
3-Year EPS without NRI Growth Rate -46.5
3-Year Book Growth Rate -9.5
Name Current Vs Industry Vs History
5-Day RSI 64.67
9-Day RSI 52.88
14-Day RSI 49.47
6-1 Month Momentum % 12.62
12-1 Month Momentum % 2.56

Liquidity Ratio

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2024-06-06 Est.)

HQL's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NYSE:HQL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

abrdn Life Sciences Investors Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 23.523
EPS (TTM) ($) 0.79
Beta 0.7
Volatility % 17.24
14-Day RSI 49.47
14-Day ATR ($) 0.16479
20-Day SMA ($) 13.64975
12-1 Month Momentum % 2.56
52-Week Range ($) 11.34 - 14.37
Shares Outstanding (Mil) 26.79

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

abrdn Life Sciences Investors Filings

Filing Date Document Date Form
No Filing Data

abrdn Life Sciences Investors Stock Events

Financials Calendars
Event Date Price($)
No Event Data

abrdn Life Sciences Investors Frequently Asked Questions

What is abrdn Life Sciences Investors(HQL)'s stock price today?
The current price of HQL is $13.63. The 52 week high of HQL is $14.37 and 52 week low is $11.34.
When is next earnings date of abrdn Life Sciences Investors(HQL)?
The next earnings date of abrdn Life Sciences Investors(HQL) is 2024-06-06 Est..
Does abrdn Life Sciences Investors(HQL) pay dividends? If so, how much?
The  Dividend Yield %  of abrdn Life Sciences Investors(HQL) is 9.73% (As of Today), Highest Dividend Payout Ratio of abrdn Life Sciences Investors(HQL) was 1.62. The lowest was 0.29. And the median was 0.63. The  Forward Dividend Yield % of abrdn Life Sciences Investors(HQL) is 9.73%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1